Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000012786 | SCV001163782 | likely pathogenic | Glycogen storage disease due to glucose-6-phosphatase deficiency type IA | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000012786 | SCV001204378 | pathogenic | Glycogen storage disease due to glucose-6-phosphatase deficiency type IA | 2024-12-18 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 124 of the G6PC protein (p.Ala124Thr). This variant is present in population databases (rs104894568, gnomAD 0.01%). This missense change has been observed in individual(s) with glycogen storage disease type Ia (PMID: 8733042, 11949931). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12006). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt G6PC protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects G6PC function (PMID: 10738525, 11739393). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000012786 | SCV003833765 | likely pathogenic | Glycogen storage disease due to glucose-6-phosphatase deficiency type IA | 2021-11-30 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000012786 | SCV000033026 | pathogenic | Glycogen storage disease due to glucose-6-phosphatase deficiency type IA | 1996-05-01 | no assertion criteria provided | literature only |